Related Experiment Video
Updated: Jun 29, 2026
09:34
Reprogramming Primary Amniotic Fluid and Membrane Cells to Pluripotency in Xeno-free Conditions
Published on: November 27, 2017
Metaplasia and somatic cell reprogramming
1Stem Cell Institute, University of Minnesota, MTRF, 2001 6th Street SE, Minneapolis, MN 55455, USA. slack017@umn.edu
The Journal of Pathology
|October 16, 2008
Summary
Metaplasia involves changes in cell types, potentially driven by altered transcription factors. This research explores using transcription factors for targeted cell transformations, including creating induced pluripotential stem cells (iPS cells).
Area of Science:
- Cell Biology
- Developmental Biology
- Genetics
Background:
- Metaplasia is a reversible change in which one adult cell type is replaced by another adult cell type.
- The underlying mechanisms of metaplasia initiation are not fully understood.
- Transcription factors play a crucial role in cell differentiation and development.
Purpose of the Study:
- To review the nature and occurrence of metaplasia.
- To present a theory on metaplasia initiation based on transcription factor expression.
- To explore the potential for using transcription factors to induce specific cell transformations.
Main Methods:
- Review of existing literature on metaplasia.
- Presentation of a theoretical model for metaplasia initiation.
- Description of experimental metaplasia examples, including B lymphocyte to macrophage and pancreatic exocrine cell to hepatocyte transformations.
- Discussion of induced pluripotential stem cell (iPS cell) formation as a related process.
Main Results:
- Metaplasia may be initiated by alterations in the expression patterns of developmental transcription factors.
- Experimental induction of metaplasia was achieved through the overexpression of specific transcription factors.
- Induced pluripotential stem cell (iPS cell) generation is a stochastic process requiring selection for the desired cell type.
Conclusions:
- Transcription factor manipulation offers a potential pathway for inducing metaplasia and cell reprogramming.
- Analogous technologies could be developed to transform cells into various non-embryonic stem cell types.
- Further research into transcription factor combinations could unlock new therapeutic possibilities.
Related Concept Videos
01:29Somatic to iPS Cell Reprogramming
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for this...
01:24Methods of Nuclear Reprogramming
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for injury repair.
01:14Introduction to Nuclear Reprogramming
Nuclear reprogramming is the process of switching gene expression of one cell type to that of another cell type, usually from a differentiated cell state to an undifferentiated cell state. Differentiation occurs during processes such as development and morphogenesis, tissue regeneration, and malignancy. Cells can also be artificially induced to reprogram their gene expression by techniques such as nuclear transfer, induced pluripotency, and cell fusion. Such techniques have many applications in...
01:32Chromatin Modification in iPS Cells
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
01:24Cellular Adaptation IV: Dysplasia and Metaplasia
DysplasiaDysplasia refers to abnormal changes in the size, shape, and organization of mature cells, characterized by pleomorphism, nuclear abnormalities, and increased mitotic activity. It commonly affects epithelial tissues, including the cervix, gastrointestinal tract, respiratory mucosa, and endometrium. Although it may occur alongside hyperplasia, dysplasia is not a true adaptive response but a preneoplastic change with potential to progress to cancer.When confined above the basement...
01:06Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic cells are...